Evidence map›Paper›PMID 17225166›Full record

ArticlePsychopharmacology2007

Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.

Lisa M Lomas, Andrew C Barrett, Jolan M Terner, Donald T Lysle, Mitchell J Picker

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Opioid system and Alzheimer's disease.Neuromolecular medicine · 2012
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lisa M LomasDepartment of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3270, USA.
Andrew C Barrett
Jolan M Terner
Donald T Lysle
Mitchell J Picker
University of North Carolina at Chapel Hill · US

Funding

Opioid-Induced Immune Alterations: Sex DifferencesR01DA015709 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LYSLE, DONALD T · 2003 to 2006
$859k
BIOBEHAVIORAL ACTIONS OF PARTIAL MU AGONISTSR01DA010277 · NIDA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI PICKER, MITCHELL J · 1996 to 2003
$645k
Influence of Gonadal Hormones on Opioid AntinociceptionF31DA017404 · NIDA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI TERNER, JOLAN M · 2003 to 2004
$44k
Sex Diffrerences in Opioid AntinociceptionF31DA015273 · NIDA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI BARRETT, ANDREW C · 2002 to 2003
$31k
NIDA NIH HHS DA07244NIDA NIH HHS DA10277NIDA NIH HHS DA15273NIDA NIH HHS DA15709NIDA NIH HHS DA17404
6 · The paper itself

Abstract

rationaleSex differences in the potency of the antinociceptive effects of kappa opioids have been reported in various acute pain models with evidence suggesting that these sex differences are mediated by activity in the N-methyl-D: -aspartate (NMDA) system.

objectivesThe purpose of the present study was to evaluate sex differences in the antihyperalgesic actions of selected kappa and mixed-action opioids in a persistent pain model and determine if the NMDA system modulates these effects in a sexually dimorphic manner.

methodsUsing gonadally intact male and female F344 rats, hyperalgesia was induced by local administration of capsaicin in the tail, after which the tail was immersed in a mildly noxious thermal stimulus (45 degrees C water), and tail-withdrawal latency measured. Opioids were then administered systemically (s.c.) and locally (in the tail) alone, and in selected combinations with the noncompetitive NMDA antagonist dextromethorphan.

resultsWhen administered systemically and locally, the kappa opioids spiradoline, U69,593 and U50,488, and the mixed-action opioids butorphanol and nalbuphine, produced dose-dependent antihyperalgesic effects. Whereas the kappa opioids were generally more potent in males, sex differences were not observed with the mixed-action opioids. Peripheral receptor activity was confirmed for local administration of kappa opioids by the antagonism observed after local, but not intracerebroventricular (i.c.v.), administration of the kappa antagonist nor-binaltorphamine (nor-BNI). Dextromethorphan was equally potent in attenuating the antihyperalgesia induced by kappa opioids in both males and females.

conclusionsThese findings demonstrate sex differences in kappa opioid activity in a persistent pain model. Although an NMDA antagonist blocked the effects of kappa opioids in this model, these effects were not sexually dimorphic as reported in most acute pain models.

Indexed as

Analgesics, OpioidAnalysis of VarianceAnimalsCapsaicinDisease Models, AnimalDose-Response Relationship, DrugFemaleHyperalgesiaInflammationInjections, IntraventricularInjections, SubcutaneousMaleN-MethylaspartatePainPain MeasurementRatsAnalgesics, OpioidCapsaicinN-MethylaspartateReceptors, Opioid

Identifiers

PMID17225166
OpenAlexW2002111265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.